Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography and MRI

Breast Cancer Clinical Trial

Official title:

A Prospective Study Evaluating Breast Density and the Role of Preoperative Mammography, Ultrasound, Elastography, and Magnetic Resonance Imaging in the Detection of Breast Cancer

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00695968
• Other study ID #: BRSNSTU0024
• Secondary ID: 98159BRSNSTU0024
• Status: Terminated
• Start date: April 2008
• Est. completion date: December 2011

Study information

• Verified date: July 2012
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To determine the sensitivity, specificity, and accuracy of preoperative ultrasound, elastography, mammography and breast MRI in women with dense breast tissue diagnosed with breast cancer; to test whether elastography or MRI can improve upon routine mammogram and conventional ultrasound in women with dense breast tissue.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 9
• Est. completion date: December 2011
• Est. primary completion date: December 2011
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:- Patients must have a suspicious breast lesion detected by a physical exam, mammography or U/S . that has not been surgically resected and is being considered to undergo biopsy if clinically indicated.

• Patients must be >= 18 and < 80 years of age, and female.

• Patients must have the ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:- Patients who have already had primary surgical excision of the suspicious finding

• <18 or >80 years of age

• Pregnant or Lactating Women

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms

Locations

Country	Name	City	State
United States	Stanford University School of Medicine	Stanford	California

Sponsors (1)

Lead Sponsor	Collaborator
Stanford University

Country where clinical trial is conducted

United States,